188 related articles for article (PubMed ID: 25700323)
1. Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in China.
Lin T; Gong L
Medicine (Baltimore); 2015 Feb; 94(7):e551. PubMed ID: 25700323
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
Gouider D; Khallouli A; Maalej A; Yousfi MA; Ksiaa I; Bouguerra C; Ajili F; Khairallah M
Cornea; 2021 Jun; 40(6):726-732. PubMed ID: 33201059
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Switching from Cyclosporine A 0.05% Anionic Emulsion to Cyclosporine A 0.1% Cationic Emulsion in Patients with Dry Eye Associated with Sjögren's Syndrome.
Kim J; Moon TK; Yoon HJ; Ji YS; Yoon KC
J Ocul Pharmacol Ther; 2021 Oct; 37(8):472-478. PubMed ID: 34449255
[No Abstract] [Full Text] [Related]
4. Management of ocular surface inflammation in Sjögren syndrome.
Hyon JY; Lee YJ; Yun PY
Cornea; 2007 Oct; 26(9 Suppl 1):S13-5. PubMed ID: 17881909
[TBL] [Abstract][Full Text] [Related]
5. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
[TBL] [Abstract][Full Text] [Related]
6. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
Jee D; Park M; Lee HJ; Kim MS; Kim EC
J Cataract Refract Surg; 2015 Apr; 41(4):756-63. PubMed ID: 25487027
[TBL] [Abstract][Full Text] [Related]
7. Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
Pinto-Fraga J; López-Miguel A; González-García MJ; Fernández I; López-de-la-Rosa A; Enríquez-de-Salamanca A; Stern ME; Calonge M
Ophthalmology; 2016 Jan; 123(1):141-53. PubMed ID: 26520171
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
9. Ocular-hypertensive response to topical steroids in children.
Kwok AK; Lam DS; Ng JS; Fan DS; Chew SJ; Tso MO
Ophthalmology; 1997 Dec; 104(12):2112-6. PubMed ID: 9400772
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye.
Guzey M; Karaman SK; Satici A; Ozardali I; Sezer S; Bozkurt O
Clin Exp Ophthalmol; 2009 Aug; 37(6):541-9. PubMed ID: 19702702
[TBL] [Abstract][Full Text] [Related]
11. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
Avunduk AM; Avunduk MC; Varnell ED; Kaufman HE
Am J Ophthalmol; 2003 Oct; 136(4):593-602. PubMed ID: 14516798
[TBL] [Abstract][Full Text] [Related]
12. Increased corneal sub-basal nerve density in patients with Sjögren syndrome treated with topical cyclosporine A.
Levy O; Labbé A; Borderie V; Hamiche T; Dupas B; Laroche L; Baudouin C; Bouheraoua N
Clin Exp Ophthalmol; 2017 Jul; 45(5):455-463. PubMed ID: 27957797
[TBL] [Abstract][Full Text] [Related]
13. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
Ozek D; Kemer OE; Omma A
Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.
Lin BW; Huang WL; Wang L; Chen ZM
J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093
[TBL] [Abstract][Full Text] [Related]
16. Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensive Therapy.
Roberti G; Agnifili L; Berardo F; Riva I; Figus M; Manni G; Quaranta L; Oddone F
Adv Ther; 2018 May; 35(5):686-696. PubMed ID: 29687335
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
Park Y; Song JS; Choi CY; Yoon KC; Lee HK; Kim HS
J Ocul Pharmacol Ther; 2017 Mar; 33(2):66-72. PubMed ID: 27929721
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
Prabhasawat P; Tesavibul N; Mahawong W
Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis.
Fujishima H; Fukagawa K; Takano Y; Tanaka M; Okamoto S; Miyazaki D; Yamada J; Fukushima A; Uchio E; Nakagawa Y
J Ocul Pharmacol Ther; 2009 Jun; 25(3):265-70. PubMed ID: 19348602
[TBL] [Abstract][Full Text] [Related]
20. Lacripep for the Treatment of Primary Sjögren-Associated Ocular Surface Disease: Results of the First-In-Human Study.
Tauber J; Laurie GW; Parsons EC; Odrich MG; ;
Cornea; 2023 Jul; 42(7):847-857. PubMed ID: 35942530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
